Retinal Macroglial Responses in Health and Disease

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  De Hoz, Rosa ^a   Rojas, Blanca ^a   Ramírez, Ana I ^a   Salazar, Juan J ^a   Gallego, Beatriz I ^a   Trivinõ, Alberto ^a   Ramírez, José M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGE RELATED MACULAR DEGENERATION; ASTROCYTE; DIABETES MELLITUS; GLAUCOMA; GLIA CELL; GLIOSIS; HUMAN; MACROGLIA; MUELLER CELL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; RETINA CELL; RETINA DETACHMENT; RETINA DISEASE; RETINITIS PIGMENTOSA; REVIEW; BLOOD RETINA BARRIER; CELLULAR IMMUNITY; GENETICS; HOMEOSTASIS; METABOLISM; NERVE CELL; OXIDATIVE STRESS; PATHOLOGY; RETINA;

GLUCOSE;

ASTROCYTES; BLOOD-RETINAL BARRIER; EPENDYMOGLIAL CELLS; GLIOSIS; GLUCOSE; HOMEOSTASIS; HUMANS; IMMUNITY, CELLULAR; NEURONS; OXIDATIVE STRESS; RETINA;

EID: 84973375191     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/2954721     Document Type: Review

References (154)

1. J. M. Ramirez, A. Triviño, A. I. Ramirez, J. J. Salazar, J. Garcia-Sanchez, "Immunohistochemical study of human retinal astroglia," Vision Research, vol. 34, no. 15, pp. 1935-1946, 1994.
2. A. Perez-Alvarez, A. Araque, E. D. Martin, "Confocal microscopy for astrocyte in vivo imaging: recycle and reuse in microscopy," Frontiers in Cellular Neuroscience, vol. 7, article 51, 2013.
3. G. Tezel andM. B. Wax, "Glaucoma," Chemical Immunology and Allergy, vol. 92, pp. 221-227, 2007.
4. J. S. Penn,A. Madan,R. B. Caldwell, M. Bartoli, R. W. Caldwell, M. E. Hartnett, "Vascular endothelial growth factor in eye disease," Progress in Retinal and Eye Research, vol. 27, no. 4, pp. 331-371, 2008.
5. E. R. Kandel, J. H. Schwartz, T. M. Jessell, "Neuronas y conducta," in Principios de Neurociencia, E. R. Kandel, J. H. Schwartz, T. M. Jessell, Eds., pp. 19-35, McGraw-Hill/Interamericana, Madrid, Spain, 2001.
6. H. Kettenmann and A. Verkhratsky, "Neuroglia: the 150 years after," Trends in Neurosciences, vol. 31, no. 12, pp. 653-659, 2008.
7. A. Reichenbach and A. Bringmann, "New functions of Müller cells," Glia, vol. 61, no. 5, pp. 651-678, 2013.
8. A. Barateiro, D. Brites, A. Fernandes, "Oligodendrocyte development andmyelination in neurodevelopment: molecular mechanisms in health and disease," Current Pharmaceutical Design, vol. 22, no. 6, pp. 656-679, 2016.
9. M. Pekny, M. Pekna, A. Messing et al., "Astrocytes: a central element in neurological diseases," Acta Neuropathologica, vol. 131, no. 3, pp. 323-345, 2016.
10. J. Schnitzer, "Chapter 7 Astrocytes in mammalian retina," Progress in Retinal Research, vol. 7, pp. 209-231, 1988.
11. A. Triviño, J. M. Raḿrez, A. I. Raḿrez, J. J. Salazar, J. Garcia-Sánchez, "Retinal perivascular astroglia: an immunoperoxidase study," Vision Research, vol. 32, no. 9, pp. 1601-1607, 1992.
12. J. M. Raḿrez, A. Triviño, A. I. Raḿrez, J. J. Salazar, J. Garcá-Sanchez, "Structural specializations of human retinal glial cells," Vision Research, vol. 36, no. 14, pp. 2029-2036, 1996.
13. A. Triviño, J. M. Raḿrez, A. I. Raḿrez, J. J. Salazar, J. Garcá-Sanchez, "Comparative study of astrocytes in human and rabbit retinae," Vision Research, vol. 37, no. 13, pp. 1707-1711, 1997.
14. J. M. Raḿrez, A. Triviño, A. I. Raḿrez, J. J. Salazar, "Organization and function of astrocytes in human retina," in Understanding Glial Cells, B. Castellano, B. Gonzalez, M. Nieto-Sampedro, Eds., pp. 47-62, Kluwer Academic, Boston, Mass, USA, 1988.
15. V. Sarthy and H. Ripps, The Retinal Müller Cell: Structure and Function, Kluwer Academic, New York, NY, USA, 2001.
16. A. Reichenbach and S. R. Robinson, "Ependymoglia and ependymoglia-like cells," in Neuroglia, pp. 58-84, Oxford University Press, Oxford, UK, 1995.
17. A. Reichenbach and S. R. Robinson, "Phylogenetic constraints on retinal organisation and development," Progress in Retinal and Eye Research, vol. 15, no. 1, pp. 139-171, 1995.
18. A. Bringmann, T. Pannicke, J. Grosche et al., "Müller cells in the healthy and diseased retina," Progress in Retinal and Eye Research, vol. 25, no. 4, pp. 397-424, 2006.
19. B. I. Gallego, J. J. Salazar, R. de Hoz et al., "IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma," Journal of Neuroinflammation, vol. 9, no. 1, article 92, 2012.
20. A. I. Raḿrez, J. J. Salazar, R. de Hoz et al., "Quantification of the effect of different levels of IOP in the astroglia of the rat retina ipsilateral and contralateral to experimental glaucoma," Investigative Ophthalmology & Visual Science, vol. 51, no. 11, pp. 5690-5696, 2010.
21. A. C. Charles, J. E. Merrill, E. R. Dirksen, M. J. Sandersont, "Intercellular signaling in glial cells: calcium waves and oscillations in response to mechanical stimulation and glutamate," Neuron, vol. 6, no. 6, pp. 983-992, 1991.
22. A. H. Cornell-Bell, S. M. Finkbeiner, M. S. Cooper, S. J. Smith, "Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling," Science, vol. 247, no. 4941, pp. 470-473, 1990.
23. M. Nedergaard, B. Ransom, S. A. Goldman, "New roles for astrocytes: redefining the functional architecture of the brain," Trends in Neurosciences, vol. 26, no. 10, pp. 523-530, 2003.
24. G. Seifert, K. Schilling, C. Steinhaüser, "Astrocyte dysfunction in neurological disorders: a molecular perspective," Nature Reviews Neuroscience, vol. 7, no. 3, pp. 194-206, 2006.
25. N. A. Oberheim, T. Takano, X. Han et al., "Uniquely hominid features of adult human astrocytes,"TheJournal ofNeuroscience, vol. 29, no. 10, pp. 3276-3287, 2009.
26. F. W. Pfrieger, "Role of glia in synapse development," Current Opinion in Neurobiology, vol. 12, no. 5, pp. 486-490, 2002.
27. F. W. Pfrieger, "Role of cholesterol in synapse formation and function," Biochimica et Biophysica Acta-Biomembranes, vol. 1610, no. 2, pp. 271-280, 2003.
28. S.-D. Chen, L. Wang, X.-L. Zhang, "Neuroprotection in glaucoma: present and future," ChineseMedical Journal, vol. 126, no. 8, pp. 1567-1577, 2013.
29. A. Verkhratsky, V. Parpura, M. Pekna, M. Pekny, M. Sofroniew, "Glia in the pathogenesis of neurodegenerative diseases," Biochemical Society Transactions, vol. 42, no. 5, pp. 1291-1301, 2014.
30. J. Sanderson, D. A. Dartt, V. Trinkaus-Randall et al., "Purines in the eye: recent evidence for the physiological and pathological role of purines in the RPE, retinal neurons, astrocytes, Müller cells, lens, trabecular meshwork, cornea and lacrimal gland," Experimental Eye Research, vol. 127, pp. 270-279, 2014.
31. E. C. Johnson and J. C. Morrison, "Friend or foe Resolving the impact of glial responses in glaucoma," Journal ofGlaucoma, vol. 18, no. 5, pp. 341-353, 2009.
32. A. Araque, V. Parpura, R. P. Sanzgiri, P. G. Haydon, "Tripartite synapses: glia, the unacknowledged partner," Trends in Neurosciences, vol. 22, no. 5, pp. 208-215, 1999.
33. M. M. Halassa, T. Fellin, P. G. Haydon, "The tripartite synapse: roles for gliotransmission in health and disease," Trends in Molecular Medicine, vol. 13, no. 2, pp. 54-63, 2007.
34. G. Perea, M. Navarrete, A. Araque, "Tripartite synapses: astrocytes process and control synaptic information," Trends in Neurosciences, vol. 32, no. 8, pp. 421-431, 2009.
35. M. T. Heneka, J. J. Rodŕguez, A. Verkhratsky, "Neuroglia in neurodegeneration," Brain Research Reviews, vol. 63, no. 1-2, pp. 189-211, 2010.
36. M. Tsacopoulos and P. J. Magistretti, "Metabolic coupling between glia and neurons," The Journal of Neuroscience, vol. 16, no. 3, pp. 877-885, 1996.
37. C. L. Poitry-Yamate, S. Poitry, M. Tsacopoulos, "Lactate released by Müller glial cells is metabolized by photoreceptors from mammalian retina," Journal of Neuroscience, vol. 15, no. 7, part 2, pp. 5179-5191, 1995.
38. J. D. O. Pena, A. W. Taylor, C. S. Ricard, I. Vidal, M. R. Hernandez, "Transforming growth factor isoforms in human optic nerve heads," British Journal of Ophthalmology, vol. 83,no. 2, pp. 209-218, 1999.
39. J. D. O. Pena, O. Agapova, B. T. Gabelt et al., "Increased elastin expression in astrocytes of the lamina cribrosa in response to elevated intraocular pressure," Investigative Ophthalmology and Visual Science, vol. 42, no. 10, pp. 2303-2314, 2001.
40. R. Seitz, A. Ohlmann, E. R. Tamm, "The role ofMüller glia and microglia in glaucoma," Cell and Tissue Research, vol. 353, no. 2, pp. 339-345, 2013.
41. J. X. Wilson, "Antioxidant defense of the brain: a role for astrocytes," Canadian Journal of Physiology and Pharmacology, vol. 75, no. 10-11, pp. 1149-1163, 1997.
42. M. Schütte and P. Werner, "Redistribution of glutathione in the ischemic rat retina," Neuroscience Letters, vol. 246, no. 1, pp. 53-56, 1998.
43. M. Francke, S. Uhlmann, T. Pannicke et al., "Experimental dispase-induced retinopathy causes up-regulation of P2Y receptor-mediated calcium responses in Müller glial cells," Ophthalmic Research, vol. 35, no. 1, pp. 30-41, 2003.
44. M. Francke, F. Makarov, J. Kacza et al., "Retinal pigment epithelium melanin granules are phagocytozed byMüller glial cells in experimental retinal detachment,"TheJournal ofNeurocytology, vol. 30, no. 2, pp. 131-136, 2001.
45. A. Triviño, A. I. Raḿrez, J. J. Salazar et al., "A cholesterolenriched diet induces ultrastructural changes in retinal and macroglial rabbit cells," Experimental Eye Research, vol. 83, no. 2, pp. 357-366, 2006.
46. A. I. Raḿrez, J. J. Salazar, R. de Hoz et al., "Macroglial and retinal changes in hypercholesterolemic rabbits after normalization of cholesterol levels," Experimental Eye Research, vol. 83, no. 6, pp. 1423-1438, 2006.
47. A. Triviño, A. I. Raḿrez, J. J. Salazar, B. Rojas, R. de Hoz, J. M. Raḿrez, "Retinal changes in age-related macular degeneration," in Focus on Eye Research, O. R. Ioseliane, Ed., pp. 1-37, Nova, New York, NY, USA, 2005.
48. J. M. Raḿrez, A. I. Raḿrez, J. J. Salazar, R. de Hoz, A. Trivio, "Changes of astrocytes in retinal ageing and age-related macular degeneration," Experimental Eye Research, vol. 73, no. 5, pp. 601-615, 2001.
49. A. Triviño, R. de Hoz, B. Rojas, J. J. Salazar, A. I. Raḿrez, J. M. Raḿrez, "NPY and TH innervation in human choroidal whole-mounts," Histology and Histopathology, vol. 20, no. 2, pp. 393-402, 2005.
50. R. C. Koehler, R. J. Roman, D. R. Harder, "Astrocytes and the regulation of cerebral blood flow," Trends in Neurosciences, vol. 32, no. 3, pp. 160-169, 2009.
51. G. R. J. Gordon, S. J. Mulligan, B. A. MacVicar, "Astrocyte control of the cerebrovasculature," Glia, vol. 55, no. 12, pp. 1214-1221, 2007.
52. C. Iadecola andM. Nedergaard, "Glial regulation of the cerebral microvasculature," Nature Neuroscience, vol. 10, no. 11, pp. 1369-1376, 2007.
53. N. J. Abbott, L. Rönnbäck, E. Hansson, "Astrocyteendothelial interactions at the blood-brain barrier," Nature Reviews Neuroscience, vol. 7, no. 1, pp. 41-53, 2006.
54. S. Tout, T. Chan-Ling, H. Holländer, J. Stone, "The role of Müller cells in the formation of the blood-retinal barrier," Neuroscience, vol. 55, no. 1, pp. 291-301, 1993.
55. F. Aloisi, "Immune function of microglia," Glia, vol. 36, no. 2, pp. 165-179, 2001.
56. Y. Dong and E. N. Benveniste, "Immune function of astrocytes," Glia, vol. 36, no. 2, pp. 180-190, 2001.
57. H. K. Kimelberg and M. Nedergaard, "Functions of astrocytes and their potential as therapeutic targets," Neurotherapeutics, vol. 7, no. 4, pp. 338-353, 2010.
58. M. Pekny, U. Wilhelmsson, M. Pekna, "The dual role of astrocyte activation and reactive gliosis," Neuroscience Letters, vol. 565, pp. 30-38, 2014.
59. L. Peng, V. Parpura, A. Verkhratsky, "Neuroglia as a central element of neurological diseases: an underappreciated target for therapeutic intervention," Current Neuropharmacology, vol. 12, no. 4, pp. 303-307, 2014.
60. G. P. Lewis and S. K. Fisher, "Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression," International Review of Cytology, vol. 230, pp. 263-290, 2003.
61. M. Pekny and M. Pekna, "Astrocyte reactivity and reactive astrogliosis: costs and benefits," Physiological Reviews, vol. 94, no. 4, pp. 1077-1098, 2014.
62. B. A. Barres, "The mystery and magic of glia: a perspective on their roles in health and disease," Neuron, vol. 60,no. 3, pp. 430-440, 2008.
63. A. Ames III, "CNS energy metabolism as related to function," Brain Research Reviews, vol. 34, no. 1-2, pp. 42-68, 2000.
64. A. W. Kraft, X. Hu, H. Yoon et al., "Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice," The FASEB Journal, vol. 27, no. 1, pp. 187-198, 2013.
65. E. Lieth, A. J. Barber, B. Xu et al., "Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group," Diabetes, vol. 47, no. 5, pp. 815-820, 1998.
66. A. H. Milam, Z.-Y. Li, R. N. Fariss, "Histopathology of the human retina in retinitis pigmentosa," Progress in Retinal and Eye Research, vol. 17, no. 2, pp. 175-205, 1998.
67. D. M. Inman and P. J. Horner, "Reactive nonproliferative gliosis predominates in a chronic mousemodel of glaucoma," Glia, vol. 55, no. 9, pp. 942-953, 2007.
68. M. R. Hernandez, H. Miao, T. Lukas, "Astrocytes in glaucomatous optic neuropathy," Progress in Brain Research, vol. 173, pp. 353-373, 2008.
69. E. C. Johnson, L. M. H. Deppmeier, S. K. F. Wentzien, I. Hsu, J. C. Morrison, "Chronology of optic nerve head and retinal responses to elevated intraocular pressure," Investigative Ophthalmology & Visual Science, vol. 41, no. 2, pp. 431-442, 2000.
70. D. Lam, J. Jim, E. To, C. Rasmussen, P. L. Kaufman, J. Matsubara, "Astrocyte and microglial activation in the lateral geniculate nucleus and visual cortex of glaucomatous and optic nerve transected primates," Molecular vision, vol. 15, pp. 2217-2229, 2009.
71. M. R. Hernandez, "The optic nerve head in glaucoma: role of astrocytes in tissue remodeling," Progress in Retinal and Eye Research, vol. 19, no. 3, pp. 297-321, 2000.
72. H. González, D. Elgueta, A. Montoya, R. Pacheco, "Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases," Journal of Neuroimmunology, vol. 274, no. 1-2, pp. 1-13, 2014.
73. H. A. Quigley, S. J. McKinnon, D. J. Zack et al., "Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats," Investigative Ophthalmology & Visual Science, vol. 41, no. 11, pp. 3460-3466, 2000.
74. R. S. Chong and K. R. Martin, "Glial cell interactions and glaucoma," Current Opinion in Ophthalmology, vol. 26, no. 2, pp. 73-77, 2015.
75. A. Bringmann, I. Iandiev, T. Pannicke et al., "Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects," Progress in Retinal and Eye Research, vol. 28, no. 6, pp. 423-451, 2009.
76. N. J. Coorey, W. Shen, S. H. Chung, L. Zhu, M. C. Gillies, "The role of glia in retinal vascular disease," Clinical & Experimental Optometry, vol. 95, no. 3, pp. 266-281, 2012.
77. S. Robel, B. Berninger,M. Götz, "The stem cell potential of glia: lessons fromreactive gliosis," Nature Reviews Neuroscience, vol. 12, no. 2, pp. 88-104, 2011.
78. J. E. Burda and M. V. Sofroniew, "Reactive gliosis and the multicellular response to CNS damage and disease," Neuron, vol. 81, no. 2, pp. 229-248, 2014.
79. T. Nakazawa, M. Takeda, G. P. Lewis et al., "Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin," InvestigativeOphthalmology&Visual Science, vol. 48, no. 6, pp. 2760-2768, 2007.
80. B. S. Ganesh and S. K. Chintala, "Inhibition of reactive gliosis attenuates excitotoxicity-mediated death of retinal ganglion cells," PLoS ONE, vol. 6, no. 3,Article ID e18305, 2011.
81. H. Kettenmann, U.-K. Hanisch, M. Noda, A. Verkhratsky, "Physiology of microglia," Physiological Reviews, vol. 91, no. 2, pp. 461-553, 2011.
82. C. Barcia, C. Ros, V. Annese et al., "IFN-signaling, with the synergistic contribution of TNF-, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease," Cell Death & Disease, vol. 2, no. 4, article e142, 2011.
83. P. Bezzi, M. Domercq, L. Brambilla et al., "CXCR4-activated astrocyte glutamate release via TNF: amplification by microglia triggers neurotoxicity," Nature Neuroscience, vol. 4, no. 7, pp. 702-710, 2001.
84. H. Takeuchi, S. Jin, J. Wang et al., "Tumor necrosis factor-induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner," The Journal of Biological Chemistry, vol. 281, no. 30, pp. 21362-21368, 2006.
85. R. Kuno, Y. Yoshida, A. Nitta et al., "The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes," Brain Research, vol. 1116, no. 1, pp. 12-18, 2006.
86. J. Lee, J. Shin, M. Chun, S. Oh, "Morphological analyses on retinal glial responses to glaucomatous injury evoked by venous cauterization," AppliedMicroscopy, vol. 44,no. 1, pp. 21-29, 2014.
87. X. Yan, G. Tezel, M. B. Wax, D. P. Edward, "Matrixmetalloproteinases and tumor necrosis factor in glaucomatous optic nerve head," Archives of Ophthalmology, vol. 118, no. 5, pp. 666-673, 2000.
88. L. Yuan and A. H. Neufeld, "Tumor necrosis factor-: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head," Glia, vol. 32, no. 1, pp. 42-50, 2000.
89. E. C. Johnson, T. A. Doser,W. O. Cepurna et al., "Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma," Investigative Ophthalmology & Visual Science, vol. 52, no. 1, pp. 504-518, 2011.
90. B. C. Chauhan, "Endothelin and its potential role in glaucoma," Canadian Journal of Ophthalmology, vol. 43, no. 3, pp. 356-360, 2008.
91. X. Wang, T. L. LeVatte, M. L. Archibald, B. C. Chauhan, "Increase in endothelin B receptor expression in optic nerve astrocytes in endothelin-1 induced chronic experimental optic neuropathy," Experimental Eye Research, vol. 88, no. 3, pp. 378-385, 2009.
92. G. R. Howell, D. G. Macalinao, G. L. Sousa et al., "Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma," The Journal of Clinical Investigation, vol. 121, no. 4, pp. 1429-1444, 2011.
93. A. Z. Minton, N. R. Phatak,D. L. Stankowska et al., "Endothelin b receptors contribute to retinal ganglion cell loss in a ratmodel of glaucoma," PLoS ONE, vol. 7, no. 8,Article ID e43199, 2012.
94. H.-J. Lee, J.-E. Suk, C. Patrick et al., "Direct transfer of-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies,"The Journal of Biological Chemistry, vol. 285, no. 12, pp. 9262-9272, 2010.
95. E. S. Shin, Q. Huang, Z. Gurel, C. M. Sorenson, N. Sheibani, "High glucose alters retinal astrocytes phenotype through increased production of inflammatory cytokines and oxidative stress," PLoS ONE, vol. 9, no. 7, Article ID e103148, 2014.
96. T. Nakazawa, T. Hisatomi, C. Nakazawa et al., "Monocyte chemoattractant protein 1 mediates retinal detachmentinduced photoreceptor apoptosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 7, pp. 2425-2430, 2007.
97. C. Farina, F. Aloisi, E. Meinl, "Astrocytes are active players in cerebral innate immunity," Trends in Immunology, vol. 28,no. 3, pp. 138-145, 2007.
98. K. Biernacki, A. Prat, M. Blain, J. P. Antel, "Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells," Journal of Neuropathology & Experimental Neurology, vol. 60, no. 12, pp. 1127-1136, 2001.
99. H. B. Stolp and K. M. Dziegielewska, "Review: role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases," Neuropathology andAppliedNeurobiology, vol. 35,no. 2, pp. 132-146, 2009.
100. W. Shen, S. Li, S. H. Chung,M. C. Gillies, "Retinal vascular changes after glial disruption in rats," Journal of Neuroscience Research, vol. 88, no. 7, pp. 1485-1499, 2010.
101. K. M. Nikcevich, K. B. Gordon, L. Tan et al., "IFN-activated primary murine astrocytes express b7 costimulatory molecules and prime naive antigen-specific T cells," Journal of Immunology, vol. 158, no. 2, pp. 614-621, 1997.
102. K. Stasi, D. Nagel, X. Yang et al., "Complement component 1Q (C1Q) upregulation in retina of murine, primate, human glaucomatous eyes," Investigative Ophthalmology & Visual Science, vol. 47, no. 3, pp. 1024-1029, 2006.
103. A. Bringmann, T. Pannicke, B. Biedermann et al., "Role of retinal glial cells in neurotransmitter uptake and metabolism," Neurochemistry International, vol. 54,no. 3-4, pp. 143-160, 2009.
104. G. Luna, G. P. Lewis, C. D. Banna, O. Skalli, S. K. Fisher, "Expression profiles of nestin and synemin in reactive astrocytes and Müller cells following retinal injury: a comparison with glial fibrillar acidic protein and vimentin," Molecular Vision, vol. 16, pp. 2511-2523, 2010.
105. E. Lieth, T. W. Gardner, A. J. Barber,D. A. Antonetti, "Retinal neurodegeneration: early pathology in diabetes," Clinical & Experimental Ophthalmology, vol. 28, no. 1, pp. 3-8, 2000.
106. M. Mizutani, C. Gerhardinger, M. Lorenzi, "Müller cell changes in human diabetic retinopathy," Diabetes, vol. 47, no. 3, pp. 445-449, 1998.
107. X. Wang, S. S.-W. Tay, Y.-K. Ng, "An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma," Experimental Brain Research, vol. 132, no. 4, pp. 476-484, 2000.
108. G. Tezel, B. C. Chauhan, R. P. LeBlanc, M. B. Wax, "Immunohistochemical assessment of the glial mitogenactivated protein kinase activation in glaucoma," Investigative Ophthalmology & Visual Science, vol. 44, no. 7, pp. 3025-3033, 2003.
109. S. Bolz, F. Schuettauf, J. E. Fries, S. Thaler, A. Reichenbach, T. Pannicke, "K+ currents fail to change in reactive retinal glial cells in a mousemodel of glaucoma," Graefe's Archive for Clinical and ExperimentalOphthalmology, vol. 246, no. 9,pp. 1249-1254, 2008.
110. A. Kanamori, M. Nakamura, Y. Nakanishi, Y. Yamada, A. Negi, "Long-term glial reactivity in rat retinas ipsilateral and contralateral to experimental glaucoma," Experimental Eye Research, vol. 81, no. 1, pp. 48-56, 2005.
111. S. Zhang, H. Wang, Q. Lu et al., "Detection of early neuron degeneration and accompanying glial responses in the visual pathway in a ratmodel of acute intraocular hypertension," Brain Research, vol. 1303, pp. 131-143, 2009.
112. K. H. C. Wu, M. C. Madigan, F. A. Billson, P. L. Penfold, "Differential expression of GFAP in early v late AMD: a quantitative analysis," British Journal of Ophthalmology, vol. 87, no. 9, pp. 1159-1166, 2003.
113. A. J. Barber, D. A. Antonetti, T. W. Gardner, "Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes," Investigative Ophthalmology&Visual Science, vol. 41, no. 11, pp. 3561-3568, 2000.
114. L. Fernandez-Sanchez, G. Esquiva, I. Pinilla, J. Martn-Nieto, N. Cuenca, "The antiapoptotic TUDCA protects against mitochondrial dysfunction, Glial cell changes and loss of the capillary network in the transgenic rat model of retinitis pigmentosa P23H," Investigative Ophthalmology & Visual Science, vol. 51, no. 13, p. 3721, 2010.
115. M. Takeda, A. Takamiya, J.-W. Jiao et al., "-Aminoadipate induces progenitor cell properties of Müller glia in adult mice," Investigative Ophthalmology & Visual Science, vol. 49, no. 3, pp. 1142-1150, 2008.
116. G. P. Lewis, E. A. Chapin, G. Luna, K. A. Linberg, S. K. Fisher, "The fate of Muller's glia following experimental retinal detachment: nuclear migration, cell division, subretinal glial scar formation," Molecular Vision, vol. 16, pp. 1361-1372, 2010.
117. A. Bringmann, M. Francke, T. Pannicke et al., "Role of glial K+ channels in ontogeny and gliosis: a hypothesis based upon studies on Muller cells," Glia, vol. 29, no. 1, pp. 35-44, 2000.
118. C. Dalloz, R. Sarig, P. Fort et al., "Targeted inactivation of dystrophin gene product Dp71: phenotypic impact in mouse retina," HumanMolecular Genetics, vol. 12,no. 13,pp. 1543-1554, 2003.
119. T. Pannicke, I. Iandiev, O. Uckermann et al., "A potassium channel-linked mechanism of glial cell swelling in the postischemic retina,"Molecular and Cellular Neuroscience, vol. 26, no. 4, pp. 493-502, 2004.
120. T. Pannicke, O. Uckermann, I. Iandiev, P. Wiedemann, A. Reichenbach, A. Bringmann, "Ocular inflammation alters swelling and membrane characteristics of ratMüller glial cells," Journal of Neuroimmunology, vol. 161, no. 1-2, pp. 145-154, 2005.
121. T. Pannicke, I. Iandiev, A. Wurm et al., "Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina," Diabetes, vol. 55, no. 3, pp. 633-639, 2006.
122. I. Iandiev,A. Wurm, M. Hollborn et al., "Müller cell response to blue light injury of the rat retina," Investigative Ophthalmology &Visual Science, vol. 49, no. 8, pp. 3559-3567, 2008.
123. M. A. Dyer and C. L. Cepko, "Control of Müller glial cell proliferation and activation following retinal injury," Nature Neuroscience, vol. 3, no. 9, pp. 873-880, 2000.
124. J. M. Burke and J. M. Smith, "Retinal proliferation in response to vitreous hemoglobin or iron," Investigative Ophthalmology & Visual Science, vol. 20, no. 5, pp. 582-592, 1981.
125. J. W. Fawcett and R. A. Asher, "The glial scar and central nervous system repair," Brain Research Bulletin, vol. 49, no. 6, pp. 377-391, 1999.
126. N. Cuenca, L. Fernández-Sánchez, L. Campello et al., "Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases," Progress in Retinal and Eye Research, vol. 43, pp. 17-75, 2014.
127. A. Bringmann and A. Reichenbach, "Role of Muller cells in retinal degenerations," Frontiers in Bioscience, vol. 6, pp. E72-E92, 2001.
128. M. Frasson, S. Picaud,T. Léveillard et al., "Glial cell line-derived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse," Investigative Ophthalmology & Visual Science, vol. 40, no. 11, pp. 2724-2734, 1999.
129. M. Honjo, H. Tanihara, N. Kido, M. Inatani, K. Okazaki, Y. Honda, "Expression of ciliary neurotrophic factor activated by retinal Müller cells in eyes with NMDA-and kainic acidinduced neuronal death," Investigative Ophthalmology & Visual Science, vol. 41, no. 2, pp. 552-560, 2000.
130. H. Oku, T. Ikeda, Y. Honma et al., "Gene expression of neurotrophins and their high-affinity Trk receptors in cultured humanMüller cells," Ophthalmic Research, vol. 34, no. 1, pp. 38-42, 2002.
131. V. Sarup, K. Patil, S. C. Sharma, "Ciliary neurotrophic factor and its receptors are differentially expressed in the optic nerve transected adult rat retina," Brain Research, vol. 1013, no. 2, pp. 152-158, 2004.
132. M. E. Pease, D. J. Zack, C. Berlinicke et al., "Effect of CNTF on retinal ganglion cell survival in experimental glaucoma," Investigative Ophthalmology & Visual Science, vol. 50, no. 5, pp. 2194-2200, 2009.
133. M. Kirsch, N. Trautmann, M. Ernst, H.-D. Hofmann, "Involvement of gp130-associated cytokine signaling in Müller cell activation following optic nerve lesion," Glia, vol. 58, no. 7, pp. 768-779, 2010.
134. G. Tezel and M. B. Wax, "Hypoxia-inducible factor 1 in the glaucomatous retina and optic nerve head," Archives of Ophthalmology, vol. 122, no. 9, pp. 1348-1356, 2004.
135. C. Ergorul, A. Ray, W. Huang et al., "Hypoxia inducible factor-1 (HIF-1) and some HIF-1 target genes are elevated in experimental glaucoma," Journal ofMolecular Neuroscience, vol. 42, no. 2, pp. 183-191, 2010.
136. A. Matteucci, L. Gaddini, M. Villa et al., "Neuroprotection by ratMüller glia against high glucose-induced neurodegeneration through a mechanism involving ERK1/2 activation," Experimental Eye Research, vol. 125, pp. 20-29, 2014.
137. A. Bringmann and P. Wiedemann, "Involvement ofMüller glial cells in epiretinal membrane formation," Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 247, no. 7, pp. 865-883, 2009.
138. Y. Chu, V. A. Alder, M. F. Humphrey, I. J. Constable, "Localization of IgG in the normal and dystrophic rat retina after laser lesions," Australian and New Zealand Journal of Ophthalmology, vol. 27, no. 2, pp. 117-125, 1999.
139. S. J. Giebel, G. Menicucci, P. G. McGuire, A. Das, "Matrix metalloproteinases in early diabetic retinopathy and their role in alternation of the blood-retinal barrier," Laboratory Investigation, vol. 85, no. 5, pp. 597-607, 2005.
140. U. Kilic, E. Kilic, A. Järve et al., "Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways," The Journal of Neuroscience, vol. 26, no. 48, pp. 12439-12446, 2006.
141. I. A. Pierce, R. L. Avery, E. D. Foley, L. P. Aiello, L. E. H. Smith, "Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization," Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 3, pp. 905-909, 1995.
142. J. J. Wang, M. Zhu, Y. Z. Le, "Functions of Muller cellderived vascular endothelial growth factor in diabetic retinopathy," World Journal of Diabetes, vol. 6, no. 5, pp. 726-733, 2015.
143. S. Roth, "Role of nitric oxide in retinal cell death," Clinical Neuroscience, vol. 4, no. 5, pp. 216-223, 1997.
144. P. D. Koeberle and A. K. Ball, "Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells," Experimental Neurology, vol. 158, no. 2, pp. 366-381, 1999.
145. O. Goureau, F. Régnier-Ricard, Y. Courtois, "Requirement for nitric oxide in retinal neuronal cell death induced by activated Muller glial cells," Journal of Neurochemistry, vol. 72, no. 6, pp. 2506-2515, 1999.
146. S. Kashii, M. Mandai,M. Kikuchi et al., "Dual actions of nitric oxide in N-methyl-D-aspartate receptor-mediated neurotoxicity in cultured retinal neurons," Brain Research, vol. 711, no. 1-2, pp. 93-101, 1996.
147. C. K. Vorwerk,M. S. R. Gorla,E. B. Dreyer, "Anexperimental basis for implicating excitotoxicity in glaucomatous optic neuropathy," Survey ofOphthalmology, vol. 43, supplement 1,pp. S142-S150, 1999.
148. R. Naskar, C. K. Vorwerk, E. B. Dreyer, "Concurrent downregulation of a glutamate transporter and receptor in glaucoma," Investigative Ophthalmology & Visual Science, vol. 41, no. 7, pp. 1940-1944, 2000.
149. J. Rieck, "The pathogenesis of glaucoma in the interplay with the immune system," Investigative Ophthalmology and Visual Science, vol. 54, no. 3, pp. 2393-2409, 2013.
150. A. Cotinet, O. Goureau, B. Thillaye-Goldenberg, M. C. Naud, Y. De Kozak, "Differential tumor necrosis factor and nitric oxide production in retinal Muller glial cells from C3H/HeN andC3H/HeJ mice,"Ocular Immunology and Inflammation, vol. 5, no. 2, pp. 111-116, 1997.
151. Y. de Kozak, M.-C. Naud, J. Bellot, J.-P. Faure, D. Hicks, "Differential tumor necrosis factor expression by resident retinal cells fromexperimental uveitis-susceptible and-resistant rat strains," Journal ofNeuroimmunology, vol. 55,no. 1, pp. 1-9, 1994.
152. K. M. Drescher and J. A. Whittum-Hudson, "Modulation of immune-associated surface markers and cytokine production by murine retinal glial cells," Journal of Neuroimmunology, vol. 64, no. 1, pp. 71-81, 1996.
153. M. Wang, W. Ma, L. Zhao, R. N. Fariss, W. T. Wong, "AdaptiveMüller cell responses to microglial activationmediate neuroprotection and coordinate inflammation in the retina," Journal of Neuroinflammation, vol. 8, article 173, 2011.
154. J. M. Raḿrez, B. Rojas, B. I. Gallego et al., "Glia and bloodretinal barrier: effects of ocular hypetension," in Cardiovascular Disease II, pp. 123-162, Concept Press, Hong Kong, 2014.